Featured Research

from universities, journals, and other organizations

Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures

Date:
February 15, 2011
Source:
American Society for Gastrointestinal Endoscopy
Summary:
Researchers from Korea report that, compared with conventional sedation, balanced propofol sedation (BPS) using propofol in combination with midazolam and meperidine, provided higher health care provider satisfaction, better patient cooperation, and similar adverse event profiles in patients undergoing therapeutic endoscopic procedures. This is the first prospective study of BPS in direct comparison with conventional sedation. The researchers note that this study provides further evidence to support the adoption of endoscopist-directed BPS for therapeutic endoscopy.

Researchers from Korea report that, compared with conventional sedation, balanced propofol sedation (BPS) using propofol in combination with midazolam and meperidine, provided higher health care provider satisfaction, better patient cooperation, and similar adverse event profiles in patients undergoing therapeutic endoscopic procedures. This is the first prospective study of BPS in direct comparison with conventional sedation. The researchers note that this study provides further evidence to support the adoption of endoscopist-directed BPS for therapeutic endoscopy.

Related Articles


The study appears in the February issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

Propofol sedation for gastrointestinal (GI) endoscopy has become popular worldwide. In recent years, propofol has been used safely and effectively in advanced interventional endoscopic procedures, such as endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS), even for high risk patients. However, propofol monosedation is not risk free with interventional endoscopy, which usually entails a longer procedure time, larger doses of propofol, and potentially more frequent dose-related side effects compared with those of diagnostic endoscopies. Propofol has several disadvantages associated with its pharmacokinetic properties and therefore nonanesthesiologist-administered propofol sedation for GI endoscopy remains a highly controversial issue.

Balanced propofol sedation (BPS) combines small incremental doses of propofol with single induction doses of benzodiazepines and opioids under the direction of a physician that is not an anesthesiologist. Because BPS usually targets moderate sedation, adequate amnesia and analgesia can be achieved with concomitant administration of benzodiazepines and opioids.

"Several prospective studies have shown that BPS can be used safely and effectively for diagnostic endoscopy under the direction of a gastroenterologist. However, there are few controlled studies of BPS with direct comparison to conventional sedation in therapeutic endoscopy," said study lead author Chang Kyun Lee, MD, PhD, Kyung Hee University School of Medicine, Kyung Hee University Hospital, Seoul, Korea. "The present study was conducted to compare the safety and efficacy of BPS, propofol in combination with midazolam and meperidine, with conventional sedation, midazolam and meperidine, in patients undergoing therapeutic GI endoscopic procedures. We found that BPS provided higher health care provider satisfaction, better patient cooperation and it had similar adverse event profiles to conventional sedation."

Methods

The study's objective was to compare the safety and efficacy of BPS (propofol in combination with midazolam and meperidine) with conventional sedation (midazolam and meperidine) in patients undergoing therapeutic endoscopic procedures. The main outcome measurements were the rates of sedation-related cardiopulmonary complications and interruption of the procedures, procedure-related times, and assessments of health care providers (endoscopists and sedation nurses) and patients.

This was a single-center, prospective, randomized, single-blinded study of 222 consecutive patients referred for therapeutic esophagogastroduodenoscopy (also called EGD or upper endoscopy) or ERCP between July 2009 and March 2010. All endoscopic procedures were performed by five experienced endoscopists who were faculty at the hospital. Patients were randomly assigned to one of two sedation protocols (conventional group [midazolam and meperidine] vs. BPS group [propofol in combination with midazolam and meperidine]) by use of a computer-generated random sequence. Both randomization and the drugs used for sedation and analgesia were concealed from all patients, endoscopists, endoscopy nurses, and recovery-room nurses. However, the sedation nurses and research nurse were not blinded.

All sedatives and analgesics used for this study were administered by trained registered nurses who had advanced cardiac life support certification and were under endoscopist supervision. The nurses who administered the sedatives and analgesics were dedicated to drug administration and patient monitoring. The target level of sedation was moderate sedation based on the American Society for Anesthesiology (ASA) levels. All patients were continuously monitored for heart rate, blood pressure, and oxygen saturation until full recovery. At the end of the procedure, both the endoscopists and the sedation nurses completed a questionnaire. If full recovery was confirmed for patients in the inpatient setting, they also completed a questionnaire about overall satisfaction with the sedation and the procedure.

Results

The mean duration of induction, endoscopic procedures and recovery was not statistically different between the two groups. There were no significant differences between the BPS and conventional groups in the rates of cardiopulmonary complications (8.8 percent vs. 5.8 percent) and transient interruption of procedures (2.9 percent vs. zero). No patient required assisted ventilation or premature termination of a procedure. BPS provided significantly higher health care provider satisfaction compared with conventional sedation (as reported by both endoscopists and sedation nurses) and patient cooperation was significantly better in the BPS group. The sedation nurses were more satisfied with BPS than with conventional sedation in terms of difficulty of induction and satisfaction with the procedure. Patient assessment was similar in the two study arms. However, significantly fewer patients sedated with BPS reported memory of the endoscope insertion and withdrawal than in the conventional group.

The researchers concluded that this study provides further evidence to support the adoption of endoscopist-directed BPS for therapeutic endoscopy.

In an accompanying editorial, Lawrence B. Cohen, MD, The Mount Sinai School of Medicine, New York, New York, stated that "…this study provides us with additional evidence that endoscopist-directed propofol administration is safe and effective for select patients undergoing advanced endoscopic procedures. Yet, although our understanding of BPS has been expanded, questions regarding its efficacy and efficiency relative to conventional sedation remain. The pharmacologic principle underlying BPS also serves as a reminder of the important role of drug-drug interactions in the daily practice of gastroenterology."


Story Source:

The above story is based on materials provided by American Society for Gastrointestinal Endoscopy. Note: Materials may be edited for content and length.


Journal References:

  1. Chang Kyun Lee, Suck-Ho Lee, Il-Kwun Chung, Tae Hoon Lee, Sang-Heum Park, Eun-Ok Kim, Sae Hwan Lee, Hong-Soo Kim, Sun-Joo Kim. Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study. Gastrointestinal Endoscopy, 2011; 73 (2): 206 DOI: 10.1016/j.gie.2010.09.035
  2. Lawrence B. Cohen. Making 1 + 1 = 3: improving sedation through drug synergy. Gastrointestinal Endoscopy, 2011; 73 (2): 215 DOI: 10.1016/j.gie.2010.10.027

Cite This Page:

American Society for Gastrointestinal Endoscopy. "Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures." ScienceDaily. ScienceDaily, 15 February 2011. <www.sciencedaily.com/releases/2011/02/110215111817.htm>.
American Society for Gastrointestinal Endoscopy. (2011, February 15). Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2011/02/110215111817.htm
American Society for Gastrointestinal Endoscopy. "Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures." ScienceDaily. www.sciencedaily.com/releases/2011/02/110215111817.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins